日期:
2020 年 — 2026 年
2020
2021
2022
2023
2024
2025
2026
影响因子:

Efficacy and safety of garsorasib in patients with KRAS G12C-mutated advanced pancreatic cancer

加索拉西布治疗KRAS G12C突变晚期胰腺癌患者的疗效和安全性

Yamamoto, Noboru; Yan, Dong; Ganju, Vinod; Hou, Xinfang; Pan, Hongming; Shan, Jianzhen; Wang, Liwei; Kim, Sang-We; Richardson, Gary; Sanborn, Rachel E; Zhang, Jingdong; Xiang, Ziyong; Wang, Wenjia; Shi, Zhe; Zhang, Ling; Wang, Yaolin; Xu, Rui-Hua

Exploratory Analyses of Patient Preferences for Atezolizumab Subcutaneous Versus Intravenous from the IMscin002 Study in Patients with Non-Small Cell Lung Cancer

IMscin002 研究中非小细胞肺癌患者对阿特珠单抗皮下注射与静脉注射给药方式偏好的探索性分析

Majem, Margarita; Chewaskulyong, Busyamas; Zvirbule, Zanete; Lee, Ki Hyeong; Korbenfeld, Ernesto; Kolb-Sielecki, Jaroslaw; Castro Sanchez, Amparo Yovanna; Bustillos, Alberto; Herraez-Baranda, Luis; Liu, Xiaoyan; Kim, Sang-We; Cappuzzo, Federico

Molecular determinants of sotorasib clinical efficacy in KRAS(G12C)-mutated non-small-cell lung cancer

索托拉西布在KRAS(G12C)突变型非小细胞肺癌中临床疗效的分子决定因素

Skoulidis, Ferdinandos; Li, Bob T; de Langen, Adrianus Johannes; Hong, David S; Lena, Herve; Wolf, Juergen; Dy, Grace K; Curioni Fontecedro, Alessandra; Tomasini, Pascale; Velcheti, Vamsidhar; van der Wekken, Anthonie J; Dooms, Christophe; Paz-Ares Rodriguez, Luis; Mountzios, Giannis; Sacher, Adrian; Nadal, Ernest; Couraud, Sebastien; Kim, Sang-We; O'Byrne, Kenneth; Rocco, Danilo; Toyozawa, Ryo; Chmielewska, Izabela; Lindsay, Colin R; Hindoyan, Antreas; Mukundan, Lata; Wilmanski, Tomasz; Anderson, Abraham; Ardito-Abraham, Christine; Pati, Amrita; Reddy, Anita; Mehta, Bhakti; Schuler, Martin

Patritumab Deruxtecan (HER3-DXd; MK-1022) in Non-Small Cell Lung Cancer After Platinum-Based Chemotherapy and Immunotherapy

帕立妥单抗德鲁替康(HER3-DXd;MK-1022)用于铂类化疗和免疫治疗后的非小细胞肺癌

Steuer, Conor E; Hayashi, Hidetoshi; Su, Wu-Chou; Nishio, Makoto; Johnson, Melissa L; Kim, Dong-Wan; Massarelli, Erminia; Felip, Enriqueta; Gold, Kathryn A; Murakami, Haruyasu; Baik, Christina S; Kim, Sang-We; Smit, Egbert F; Fujimura, Masahiro; Fan, Pang-Dian; Truchon, Karine; Su, Xin; Sternberg, David W; Jänne, Pasi A

MED12 mutation induces RTK inhibitor resistance in NSCLC via MEK/ERK pathway activation by inflammatory cytokines.

MED12 突变通过炎症细胞因子激活 MEK/ERK 通路,诱导 NSCLC 对 RTK 抑制剂产生耐药性

Ryu Hyun-Min, Kim Deokhoon, Choi Jun Young, Yoon Shinkyo, Lee Ho-Su, Park Ji Eun, Lee Eunjin, Sung Yunkyung, Lee Chang Hoon, Lee Eun-Young, Kim Wanlim, Seo Seyoung, Kim Sang-We, Park Kang-Seo, Lee Dae Ho

Pooled safety analysis and management of sotorasib-related adverse events in KRAS G12C-mutated advanced non-small cell lung cancer

KRAS G12C 突变型晚期非小细胞肺癌中 sotorasib 相关不良事件的汇总安全性分析和管理

Skoulidis, Ferdinandos; Li, Bob T; Hochmair, Maximilian; Govindan, Ramaswamy; Vincent, Mark; van der Wekken, Anthonie J; Reguart Aransay, Noemi; O'Byrne, Kenneth J; Girard, Nicolas; Griesinger, Frank; Nishio, Makoto; Häfliger, Simon; Lindsay, Colin; Reinmuth, Niels; Paulus, Astrid; Papakotoulas, Pavlos; Kim, Sang-We; Ferreira, Carlos Gil; Pasello, Giulia; Duruisseaux, Michael; Gennatas, Spyridon; Dimou, Anastasios; Mehta, Bhakti; Kormany, William; Nduka, Chidozie; Sylvester, Brooke E; Ardito-Abraham, Christine; Wang, Yang; de Langen, Adrianus Johannes

The Survival and Financial Benefit of Investigator-Initiated Trials Conducted by Korean Cancer Study Group

韩国癌症研究组开展的研究者发起试验的生存率和经济效益

Kim, Bum Jun; Maeng, Chi Hoon; Keam, Bhumsuk; Im, Young-Hyuck; Ro, Jungsil; Jung, Kyung Hae; Im, Seock-Ah; Kim, Tae Won; Lee, Jae Lyun; Heo, Dae Seog; Kim, Sang-We; Park, Keunchil; Ahn, Myung-Ju; Cho, Byoung Chul; Kim, Hoon-Kyo; Kang, Yoon-Koo; Cho, Jae Yong; Yun, Hwan Jung; Nam, Byung-Ho; Zang, Dae Young

Exon-level TP53 alterations and PD-L1 expression identified by pretreatment NGS stratify survival in EGFR-mutant non-small cell lung cancer treated with first-line osimertinib

通过治疗前NGS检测发现的TP53外显子水平改变和PD-L1表达可对接受一线奥希替尼治疗的EGFR突变型非小细胞肺癌患者的生存期进行分层。

Kim, Seong-Eun; Kim, Yongjae; Yoon, Do Kyung; Park, Hwan; Park, Kang-Seo; Kim, Deokhoon; Hwang, Hee Sang; Ahn, Bokyung; Park, Ji Eun; Kim, Sang-We; Jang, Se Jin; Yoon, Shinkyo; Lee, Ho-Su; Lee, Dae Ho

Durvalumab With or Without Tremelimumab in Combination With Chemoradiotherapy in Patients With Limited-Stage SCLC: Results from the Phase 1 CLOVER Study

度伐利尤单抗联合或不联合曲美利木单抗与放化疗治疗局限期小细胞肺癌患者:CLOVER 1期研究结果

Cho, Byoung Chul; Ahn, Myung-Ju; Nishio, Makoto; Murakami, Haruyasu; Wan-Kim, Dong; Kim, Sang-We; Karam, Sana D; Estival, Ana; Lin, Chia-Chi; Trigo, Jose Manuel; Alvarez, Rosa; Wang, Chih Liang; Xie, Mingchao; Iyer, Sonia; Armstrong, Jon; Chugh, Priti; Jiang, Haiyi; Bauman, Julie E

Sotorasib versus docetaxel for previously treated KRAS G12C-mutated non-small-cell lung cancer: a plain language summary

索托拉西布与多西他赛治疗既往接受过治疗的KRAS G12C突变型非小细胞肺癌:简明扼要的总结

de Langen, Adrianus Johannes; Johnson, Melissa L; Mazieres, Julien; Dingemans, Anne-Marie C; Mountzios, Giannis; Pless, Miklos; Wolf, Jürgen; Schuler, Martin; Lena, Hervé; Skoulidis, Ferdinandos; Yoneshima, Yasuto; Kim, Sang-We; Linardou, Helena; Novello, Silvia; van der Wekken, Anthonie J; Chen, Yuanbin; Peters, Solange; Felip, Enriqueta; Solomon, Benjamin J; Ramalingam, Suresh S; Dooms, Christophe; Lindsay, Colin R; Ferreira, Carlos Gil; Blais, Normand; Obiozor, Cynthia C; Wang, Yang; Mehta, Bhakti; Varrieur, Tracy; Ngarmchamnanrith, Gataree; Stollenwerk, Björn; Waterhouse, David; Paz-Ares, Luis